Roger E. G. Schutgens

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

Wolfgang Miesbach, Karina Meijer, Michiel Coppens et al. · Blood · 2017 · 301 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Clinical severity of haemophilia A: does the classification of the 1950s still stand?

I. E. M. DEN UIJL, E. P. Mauser Bunschoten, G. Roosendaal et al. · Haemophilia · 2011 · 244 citations

Medicine, Hematology, Pediatrics +13

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia

Martin Teraa, Ralf W. Sprengers, Roger E. G. Schutgens et al. · Circulation · 2015 · 181 citations · Full text

Medicine, Surgery, Cell Therapy +13

Combination of a Normal D-Dimer Concentration and a Non-High Pretest Clinical Probability Score Is a Safe Strategy to Exclude Deep Venous Thrombosis

Roger E. G. Schutgens, Pernilla Y Ackermark, Fred J.L.M. Haas et al. · Circulation · 2003 · 176 citations

Medicine, Clinical Sciences, Internal Medicine +17

Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level

Mariëtte J Agterof, Roger E. G. Schutgens, Repke J. Snijder et al. · Journal of Thrombosis and Haemostasis · 2010 · 137 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8